Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart monitor reveals hidden damage from cancer radiation

NCT ID NCT04183218

Completed Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looked at 24 people with lung or esophageal cancer who received radiation or chemo-radiation near the heart. Participants wore a small heart monitor to catch any heart changes that might otherwise go unnoticed. The goal was to see how often heart problems occur after such treatment, so doctors can manage them earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors detect and treat heart problems early in cancer patients receiving radiation near the heart.

What could go wrong

This is a small, completed observational study with only 24 participants, so results may not apply to everyone. It does not test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE IIIB LUNG CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma of esophagus esophageal adenocarcinoma esophageal cancer esophageal squamous cell carcinoma esophagus carcinoma in situ lung cancer lung carcinoma lung carcinoma in situ lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CLINICAL STAGE 0 ESOPHAGEAL ADENOCARCINOMA AJCC V8 CLINICAL STAGE 0 ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 CLINICAL STAGE I ESOPHAGEAL ADENOCARCINOMA AJCC V8 CLINICAL STAGE I ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 CLINICAL STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8 CLINICAL STAGE II ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 CLINICAL STAGE IIA ESOPHAGEAL ADENOCARCINOMA AJCC V8 CLINICAL STAGE IIB ESOPHAGEAL ADENOCARCINOMA AJCC V8 CLINICAL STAGE III ESOPHAGEAL ADENOCARCINOMA AJCC V8 CLINICAL STAGE III ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 LOCALIZED ESOPHAGEAL CARCINOMA LOCALIZED LUNG CARCINOMA PATHOLOGIC STAGE 0 ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE 0 ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 PATHOLOGIC STAGE I ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE I ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 PATHOLOGIC STAGE IA ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE IA ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 PATHOLOGIC STAGE IB ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE IB ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 PATHOLOGIC STAGE IC ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE II ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 PATHOLOGIC STAGE IIA ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE IIA ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 PATHOLOGIC STAGE IIB ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE IIB ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 PATHOLOGIC STAGE III ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE III ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 PATHOLOGIC STAGE IIIA ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE IIIA ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 PATHOLOGIC STAGE IIIB ESOPHAGEAL ADENOCARCINOMA AJCC V8 PATHOLOGIC STAGE IIIB ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE I ESOPHAGEAL ADENOCARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE I ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE II ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE III ESOPHAGEAL ADENOCARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE III ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE IIIA ESOPHAGEAL ADENOCARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE IIIA ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE IIIB ESOPHAGEAL ADENOCARCINOMA AJCC V8 POSTNEOADJUVANT THERAPY STAGE IIIB ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 STAGE 0 LUNG CANCER AJCC V8 STAGE I LUNG CANCER AJCC V8 STAGE IA1 LUNG CANCER AJCC V8 STAGE IA2 LUNG CANCER AJCC V8 STAGE IA3 LUNG CANCER AJCC V8 STAGE IB LUNG CANCER AJCC V8 STAGE II LUNG CANCER AJCC V8 STAGE IIA LUNG CANCER AJCC V8 STAGE IIB LUNG CANCER AJCC V8 STAGE III LUNG CANCER AJCC V8 STAGE IIIA LUNG CANCER AJCC V8 STAGE IIIB LUNG CANCER AJCC V8 STAGE IIIC LUNG CANCER AJCC V8

Contacts and locations

Locations

  • Mayo Clinic in Arizona

    Scottsdale, Arizona, 85259, United States